ATE252570T1 - Verfahren zur herstellung von 5-cyanophthalid - Google Patents

Verfahren zur herstellung von 5-cyanophthalid

Info

Publication number
ATE252570T1
ATE252570T1 AT00900501T AT00900501T ATE252570T1 AT E252570 T1 ATE252570 T1 AT E252570T1 AT 00900501 T AT00900501 T AT 00900501T AT 00900501 T AT00900501 T AT 00900501T AT E252570 T1 ATE252570 T1 AT E252570T1
Authority
AT
Austria
Prior art keywords
sup
sub
cyanophthalide
alkyl
hydrogen
Prior art date
Application number
AT00900501T
Other languages
English (en)
Inventor
Hans Petersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE252570T1 publication Critical patent/ATE252570T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
AT00900501T 2000-01-14 2000-01-14 Verfahren zur herstellung von 5-cyanophthalid ATE252570T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2000/000016 WO2001051477A1 (en) 2000-01-14 2000-01-14 Method for the preparation of 5-cyanophthalide

Publications (1)

Publication Number Publication Date
ATE252570T1 true ATE252570T1 (de) 2003-11-15

Family

ID=8149377

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900501T ATE252570T1 (de) 2000-01-14 2000-01-14 Verfahren zur herstellung von 5-cyanophthalid

Country Status (27)

Country Link
US (1) US6911548B2 (de)
EP (1) EP1254129B1 (de)
JP (1) JP2003519691A (de)
KR (1) KR100660802B1 (de)
CN (1) CN1195749C (de)
AT (1) ATE252570T1 (de)
AU (1) AU3033700A (de)
CA (1) CA2397270C (de)
CZ (1) CZ20022601A3 (de)
DE (1) DE60006163T2 (de)
DK (1) DK1254129T3 (de)
EA (1) EA005134B1 (de)
ES (1) ES2206177T3 (de)
HK (1) HK1054392B (de)
HU (1) HUP0300343A2 (de)
IL (2) IL150561A0 (de)
IS (1) IS2168B (de)
IT (1) ITMI20010040A1 (de)
MX (1) MXPA02006915A (de)
NO (1) NO20023405L (de)
PL (1) PL197821B1 (de)
PT (1) PT1254129E (de)
SI (1) SI1254129T1 (de)
SK (1) SK286879B6 (de)
TR (1) TR200201783T2 (de)
UA (1) UA72569C2 (de)
WO (1) WO2001051477A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1173431T4 (da) 1999-04-14 2010-01-04 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
JP2003519136A (ja) 1999-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
DK1246813T3 (da) 1999-12-30 2004-03-01 Lundbeck & Co As H Fremgangsmåde til fremstilling af Citalopram
AU3033700A (en) 2000-01-14 2001-07-24 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
AU2001242298A1 (en) 2000-03-13 2001-09-24 H Lunbeck A/S Method for the preparation of citalopram
KR20020080485A (ko) 2000-03-13 2002-10-23 하. 룬트벡 아크티에 셀스카브 5-치환 1-(4-플루오로페닐)-1,3-디히드로이소벤조푸란의단계적 알킬화
ES2214400T3 (es) 2000-03-14 2004-09-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
US6794515B2 (en) 2002-05-15 2004-09-21 Genzyme Corporation Synthesis of 2-alkylcysteine via substituted thiazoline amide
WO2005111010A1 (en) * 2004-05-13 2005-11-24 Suven Life Sciences Ltd, An improved process for the preparation of 5-cyanophthalide
CN116022748B (zh) * 2022-12-16 2024-02-27 山东惟普新能源有限公司 一种含水双氟磺酰亚胺锂的除水方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
SK283309B6 (sk) 1997-07-08 2003-05-02 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
DK1042310T3 (da) * 1997-11-11 2002-12-02 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
ES2189502T3 (es) * 1998-10-20 2003-07-01 Lundbeck & Co As H Metodo para la prevencion de citalopram.
IL143422A0 (en) * 1998-12-23 2002-04-21 Lundbeck & Co As H Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
DK1173431T4 (da) * 1999-04-14 2010-01-04 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
CH692421A5 (de) 1999-10-25 2002-06-14 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram.
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
US6310222B1 (en) * 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
JP2003519136A (ja) 1999-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
DK1246813T3 (da) 1999-12-30 2004-03-01 Lundbeck & Co As H Fremgangsmåde til fremstilling af Citalopram
AU3033700A (en) 2000-01-14 2001-07-24 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
CA2360303C (en) 2000-12-22 2003-08-12 Marco Villa Process for the preparation of pure citalopram
SK284418B6 (sk) * 2000-12-28 2005-04-01 H. Lundbeck A/S Spôsob výroby citalopramu

Also Published As

Publication number Publication date
NO20023405L (no) 2002-08-30
PL197821B1 (pl) 2008-04-30
IL150561A (en) 2007-07-04
KR20020073501A (ko) 2002-09-26
ES2206177T3 (es) 2004-05-16
HK1054392A1 (en) 2003-11-28
SK286879B6 (sk) 2009-07-06
EA005134B1 (ru) 2004-12-30
EP1254129B1 (de) 2003-10-22
EP1254129A1 (de) 2002-11-06
US6911548B2 (en) 2005-06-28
UA72569C2 (uk) 2005-03-15
CA2397270C (en) 2007-08-21
HK1054392B (zh) 2005-11-18
DE60006163T2 (de) 2004-04-15
CA2397270A1 (en) 2001-07-19
MXPA02006915A (es) 2002-10-23
IS6449A (is) 2002-06-28
CN1423643A (zh) 2003-06-11
AU3033700A (en) 2001-07-24
CN1195749C (zh) 2005-04-06
NO20023405D0 (no) 2002-07-15
TR200201783T2 (tr) 2002-12-23
KR100660802B1 (ko) 2006-12-26
JP2003519691A (ja) 2003-06-24
SI1254129T1 (en) 2004-02-29
WO2001051477A1 (en) 2001-07-19
US20030013895A1 (en) 2003-01-16
ITMI20010040A1 (it) 2002-07-11
HUP0300343A2 (hu) 2003-06-28
PT1254129E (pt) 2004-03-31
DK1254129T3 (da) 2004-03-29
SK11662002A3 (sk) 2003-01-09
EA200200758A1 (ru) 2002-12-26
IL150561A0 (en) 2003-02-12
CZ20022601A3 (cs) 2002-10-16
IS2168B (is) 2006-11-15
DE60006163D1 (de) 2003-11-27
PL356712A1 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
BG105457A (en) Method for the preparation of citalopram
ATE252570T1 (de) Verfahren zur herstellung von 5-cyanophthalid
WO2002003984A3 (en) Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
EA200500037A1 (ru) Фенилбензамиды
KR970027031A (ko) 일차 또는 이차 알콜의 산화방법
EA199900301A2 (ru) Замещенные трициклические соединения
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
EA199900304A2 (ru) Замещенные трициклические соединения
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
ATE275561T1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
DE69908909D1 (de) Verfahren zur herstellung von simvastatin und ihren derivaten
ATE257832T1 (de) Verfahren zur herstellung von citalopram
DE502004002562D1 (de) Verfahren zur herstellung hochreiner polyalkylenglykole
GT199900047A (es) Procedimiento para alquilar sulfonamidas impedidas estèricamente.
ATE294168T1 (de) Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
ATE352542T1 (de) Tensid
DK1392672T3 (da) Chlormethylering af thiopen
ATE249450T1 (de) Verfahren zur herstellung von l-ascorbinsäure
ATE210114T1 (de) Herstellung von di-tert-peroxiden
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
ATE307794T1 (de) Verfahren zur herstellung von chlorcarbonsäurechloriden
BR0017002A (pt) Método para a preparação de 5-cianoftalida
ES2190610T3 (es) Sintesis de 3-carbometoxi-4,5-dimetiltiofeno.
JPS5583778A (en) Large-ring oxalkyl lactone having side chain and its preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1254129

Country of ref document: EP

REN Ceased due to non-payment of the annual fee